Suven Life receives three patents for CNS drug
The company has received product patents in Israel, Japan and South Africa
BS B2B Bureau B2B Connect | Hyderabad
The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Parkinson and
Schizophrenia.
With these new patents, Suven has been granted six, 17 and 20 product patents from Israel, Japan and South Africa respectively. These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts.
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jun 30 2015 | 3:09 PM IST